FDA DEVICE FACTS
Hypotension Decision Assist Model HDA-OR2
Directed Systems, Ltd.
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
HDA is indicated to acquire, process and display arterial pressure and other key cardiovascular characteristics of adult patients who are at least eighteen years of age that are undergoing surgery where their arterial pressure is being continuously monitored by a vital-signs monitor. It is indicated for use to assist anesthesia healthcare professionals manage the blood pressure, hemodynamic stability and the cardiovascular system during such surgery. Comparison of Technological Characteristics with the Predicate Device: HDA-OR2 has the same intended use and indications for use as the HDA-OR1 predicate. They are both intended to assist physicians to manage the blood pressure and cardiovascular stability of patients undergoing anesthesia during surgery. The subject and predicate device have the following same technological characteristics:
• Clinical decision support software
• Supplied on a medical grade touch screen computer
• Used with patients whose arterial pressure is being continuously monitored by a vital signs monitor.
• Input data received from a vital signs monitor
• Allows serial connection to vital signs monitor
• Input data received using same communications protocols
• Acquires arterial waveform signal provided by the vital signs monitor 002_Updated Summary
• Derives and displays from the input arterial waveform signal ; systolic blood pressure, diastolic blood pressure, MAP, heart rate, and short term changes in heart rate, cardiac output and systemic vascular resistance
• Provides clinicians with a graphical display of monitoring and support information as a visual aid in determining a patient’s cardiovascular state.
• Allows marking of the administration of bolus or infused vasopressors and volume challenges The following differences in technological characteristics exist between the subject and
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。